Sign in

CIK 0001785279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Metagenomi Therapeutics, Inc.

Sign in to watch
Ticker
MGX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
813909017
Phone
(510) 871-4880
Business address
5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA, 94608
Former names
Metagenomi, Inc., Metagenomi Technologies, LLC
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 8-K Event Regulation FD disclosure
  4. 4 Insider Changes in Ownership
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 8-K Event Executive or director change · Shareholder vote results
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations · Regulation FD disclosure

Page 1 of 8 · 156 filings